Floatz logo

Fludarabine

B-Cell Chronic Lymphocytic Leukemia

Ohio State University Comprehensive Cancer CenterSmall moleculePhase 4 / ApprovedActive
BBB
75/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
71/ 100
Competitive Position
81/ 100

Competitive context

66 Active assets in the B-Cell Chronic Lymphocytic Leukemia cohort.

Asset / SponsorPhaseRating
Humax-Cd20
Emory University
Phase 4BBB
Acalabrutinib
Zulfa Omer
Phase 4BBB
Rituximab
Zulfa Omer
Phase 4BBB
Cyclophosphamide
Ohio State University Comprehensive Cancer Center
Phase 4BBB
Obinutuzumab
Paolo Caimi, MD
Phase 3BB

View all 50 →

Same molecule, other indications

Fludarabine is also rated in:

adult T-cell leukemia/lymphomaActive
BBB
Indicative · Phase 2
76 / 100
View asset →
acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)Dormant
BBB
Indicative · Phase 2
76 / 100
View asset →
Fanconi anemiaActive
BBB
Indicative · Phase 2/3
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →